Real-time enrollment status for this systemic lupus erythematosus clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 5:04 AM UTC
| NCT Number | NCT06617325 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus |
| Phase | PHASE3 |
| Target Enrollment | 450 participants |
| Active Locations | 63 sites in the US |
| Sponsor | UCB Biopharma SRL |
| Last Updated on CT.gov | October 15, 2026 (3 days ago) |
As of October 18, 2026: Clinical trial NCT06617325 is currently recruiting participants. This phase3 study for systemic lupus erythematosus is actively seeking new participants at 63 locations across the United States. The study is sponsored by UCB Biopharma SRL. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06617325 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 63 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06617325 was last updated 3 days ago (October 15, 2026). HelloStudys verifies this status automatically.